Skip to main content

RESTORE: An RCT to Evaluate the Efficacy of the Revi System

Active, not recruiting · Not applicable · NCT06217328

Conditions: Urinary Urge Incontinence

At a glance

Research payments reported, 2025
$1.3M
U.S. investigators named
32
Sites paid
29
Planned or actual enrollment
117

About the trial

Sponsor
BlueWind Medical
Tested
Revi System Treatment (device), Revi System - Delayed Activation (device)
Dates
Started 2024-02-24; completion 2027-02-28
Results posted
Not yet

The Revi System is indicated for the treatment of patients with symptoms of urgency incontinence alone or in combination with urinary urgency.

From ClinicalTrials.gov, last updated 2026-06-23. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Bluewind Medical reported $1.3M in research payments for this study in 2025 (519 payments).

Products named: Revi

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Us-32 Specialty Clinical Research LLC $243,063
  • Us-33 Next Stage Clinical Research LLC $153,293
  • Us-31 Upnt Research Institute LLC $109,080
  • Us-28 Arizona Urology Specialists $86,082
  • Next Stage Clinical Research LLC $80,183
  • Us-36 Riverside Medical Clinic $66,342
  • Us-02 Adult Pediatric Urology & Urogynecology $53,235
  • Uh Cleveland Medical Center, OH $52,611
  • Us-26 the University of Texas Southwestern Medical Center $51,630
  • Us-01 Sanford Research $49,964
  • Duke University Hospital, NC $47,655
  • Arizona Urology Specialists $42,784
  • Chesapeake Urology Research Associates (us-03 Us-11) $38,317
  • Specialty Clinical Research LLC $25,390
  • University of Utah Hospital and Clinics, UT $25,175
  • Us-06 Gulf Coast Clinical Trial Associates $22,858
  • Willis Knighton Medical Center, LA $15,470
  • Us-24 Biomedical Research Alliance of New York LLC $14,570
  • Us-25 Dhr Health Institute for Research and Development $12,107
  • Us-30 Folio Clinical Research Organization $10,533
  • Us-34 the University of Chicago $9,295
  • Us-35 the Urology Place $8,826
  • Upnt Research Institute LLC $7,990
  • University of Alabama Hospital, AL $7,425
  • Biomedical Research Alliance of New York LLC $6,115
  • Us-02 the Urology Center PC $5,406
  • Folio Clinical Research Organization $3,768
  • Sanford Research $3,619
  • Adult Pediatric Urology & Urogynecology $3,414

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.